Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACONWNASDAQ:AONCNASDAQ:DHACWNASDAQ:PIIIW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACONWAclarion$0.04-0.3%$0.04$0.01▼$0.24N/AN/A41,802 shs3,856 shsAONCAmerican Oncology Network$11.96+8.7%$7.08$1.01▼$11.96N/AN/A2,587 shs12,443 shsDHACWDigital Health Acquisition$0.04-23.7%$0.04$0.01▼$0.40N/AN/A71,147 shs2,000 shsPIIIWP3 Health Partners$0.01-2.3%$0.01$0.01▼$0.09N/AN/A28,966 shs16,708 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACONWAclarion-0.28%-1.92%-3.25%-41.76%-7.99%AONCAmerican Oncology Network+8.73%+4.36%+71.10%+106.92%+872.36%DHACWDigital Health Acquisition0.00%-24.00%+4.11%+2.43%-76.25%PIIIWP3 Health Partners-2.30%-15.84%-24.11%-34.62%-86.92%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACONWAclarionN/AN/AN/AN/AN/AN/AN/AN/AAONCAmerican Oncology NetworkN/AN/AN/AN/AN/AN/AN/AN/ADHACWDigital Health AcquisitionN/AN/AN/AN/AN/AN/AN/AN/APIIIWP3 Health PartnersN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACONWAclarion 0.00N/AN/AN/AAONCAmerican Oncology Network 0.00N/AN/AN/ADHACWDigital Health Acquisition 0.00N/AN/AN/APIIIWP3 Health Partners 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACONWAclarion$54.60KN/AN/AN/AN/AN/AAONCAmerican Oncology Network$1.34BN/AN/AN/AN/AN/ADHACWDigital Health AcquisitionN/AN/AN/AN/AN/AN/APIIIWP3 Health Partners$1.49BN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACONWAclarionN/AN/A0.00∞N/AN/AN/AN/AN/AAONCAmerican Oncology NetworkN/AN/A0.00∞N/AN/AN/AN/AN/ADHACWDigital Health AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/APIIIWP3 Health PartnersN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACONWAclarionN/AN/AN/AN/AN/AAONCAmerican Oncology NetworkN/AN/AN/AN/AN/ADHACWDigital Health AcquisitionN/AN/AN/AN/AN/APIIIWP3 Health PartnersN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACONWAclarionN/AAONCAmerican Oncology NetworkN/ADHACWDigital Health AcquisitionN/APIIIWP3 Health PartnersN/AInsider OwnershipCompanyInsider OwnershipACONWAclarionN/AAONCAmerican Oncology NetworkN/ADHACWDigital Health AcquisitionN/APIIIWP3 Health PartnersN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACONWAclarion7N/AN/ANot OptionableAONCAmerican Oncology Network1,520N/AN/ANot OptionableDHACWDigital Health AcquisitionN/AN/AN/ANot OptionablePIIIWP3 Health Partners500N/AN/ANot OptionablePIIIW, ACONW, AONC, and DHACW HeadlinesRecent News About These CompaniesP3 Health Partners’ Shareholders Approve Key ProposalsJune 10, 2025 | tipranks.comP3 Health Partners Secures $70M Financing DealJune 3, 2025 | tipranks.comP3 Health Partners price target lowered to $8 from $12.50 at TD CowenMay 30, 2025 | finance.yahoo.comP3 Health Partners Reports Q1 2025 Financial ResultsMay 16, 2025 | tipranks.comP3 Health Partners Inc. (NASDAQ:PIII) Q4 2024 Earnings Call TranscriptMarch 29, 2025 | msn.comP3 Health Partners’ Earnings Call: Growth Amid ChallengesMarch 28, 2025 | tipranks.comP3 Health Partners targets profitability in 2025 with adjusted EBITDA guidance of up to $5MMarch 28, 2025 | msn.comP3 Health Partners targets profitability in 2025 with adjusted EBITDA guidance of up to $5MMarch 28, 2025 | msn.com6PIII : Earnings Preview For P3 Health PartnersMarch 26, 2025 | benzinga.comKuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law FirmFebruary 17, 2025 | investing.comKuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law FirmFebruary 10, 2025 | investing.comDA Davidson cuts P3 Health stock target to $60, keeps Buy ratingJanuary 30, 2025 | msn.comP3 Health Partners Inc. (PIIIW)January 25, 2025 | ca.finance.yahoo.comP3 Health Partners (PIII) Makes Waves: What’s Behind the Stock Surge?January 14, 2025 | bovnews.comBTIG Research Just Downgraded P3 Health Partners Inc (PIII) Stock—What Does This Mean for Investors?January 14, 2025 | bovnews.comP3 Health Partners to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 13, 2025 | finance.yahoo.comP3 Health Partners Secures $25M Financing AgreementDecember 18, 2024 | markets.businessinsider.comP3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity ConferenceNovember 27, 2024 | uk.finance.yahoo.comP3 Health Partners stock target cut, hold rating continued on Q3 resultsNovember 22, 2024 | uk.investing.comP3 Health Partners Inc (PIII) Stock: More Strategic Than Meets the EyeNovember 21, 2024 | bovnews.comMedia Sentiment Over TimePIIIW, ACONW, AONC, and DHACW Company DescriptionsAclarion NASDAQ:ACONW$0.04 0.00 (-0.28%) As of 06/16/2025 03:36 PM EasternAclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.American Oncology Network NASDAQ:AONC$11.96 +0.96 (+8.73%) As of 06/16/2025 03:52 PM EasternAmerican Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.Digital Health Acquisition NASDAQ:DHACW$0.04 -0.01 (-23.69%) As of 06/13/2025Digital Health Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on technology and healthcare focused businesses. Digital Health Acquisition Corp. was incorporated in 2021 and is based in Boca Raton, Florida.P3 Health Partners NASDAQ:PIIIW$0.0085 0.00 (-2.30%) As of 06/16/2025 03:42 PM EasternP3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
